Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events
High-dose intravenous immunoglobulin (IVIG) therapy is used in patients with severe autoimmune blistering diseases that are refractory to standard immunosuppressive therapy. To determine the efficacy and frequency of adverse events of WIG therapy, we retrospectively analysed data for 16 patients wit...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
Acta dermato-venereologica
Year: 2012, Jahrgang: 93, Heft: 3, Pages: 346-349 |
| ISSN: | 1651-2057 |
| DOI: | 10.2340/00015555-1471 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.2340/00015555-1471 Verlag, kostenfrei, Volltext: https://www.ingentaconnect.com/content/mjl/adv/2013/00000093/00000003/art00018 
|
| Verfasserangaben: | Vera Seidling, Jochen H.O. Hoffmann, Alexander H. Enk and Eva N. Hadaschik |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1577032799 | ||
| 003 | DE-627 | ||
| 005 | 20220814181540.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180629r20132012xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2340/00015555-1471 |2 doi | |
| 035 | |a (DE-627)1577032799 | ||
| 035 | |a (DE-576)507032799 | ||
| 035 | |a (DE-599)BSZ507032799 | ||
| 035 | |a (OCoLC)1341012934 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Seidling, Vera |d 1985- |e VerfasserIn |0 (DE-588)103109377X |0 (DE-627)735650780 |0 (DE-576)378505726 |4 aut | |
| 245 | 1 | 0 | |a Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease |b high efficacy and no serious adverse events |c Vera Seidling, Jochen H.O. Hoffmann, Alexander H. Enk and Eva N. Hadaschik |
| 264 | 1 | |c 2013 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Epub ahead of print Oct 16, 2012 | ||
| 500 | |a Gesehen am 29.06.2018 | ||
| 520 | |a High-dose intravenous immunoglobulin (IVIG) therapy is used in patients with severe autoimmune blistering diseases that are refractory to standard immunosuppressive therapy. To determine the efficacy and frequency of adverse events of WIG therapy, we retrospectively analysed data for 16 patients with pemphigus vulgaris, pemphigus foliaceus, paraneoplastic pemphigus, bullous pemphigoid and paraneoplastic bullous pemphigoid. Frequency of adverse reactions and efficacy of IVIG were analysed over time with a scoring system for every 6 months of WIG therapy. Headache (43.8%) and fatigue (43.8%) were the most common side-effects recorded; serious adverse reactions did not occur. There was good overall efficacy, as measured by clinical response rates using a clinical score, as well as indicated by a mean reduction of 75.8% in the starting steroid dose. | ||
| 534 | |c 2012 | ||
| 650 | 4 | |a autoimmune mucocutaneous blistering disease | |
| 650 | 4 | |a bullous pemphigoid | |
| 650 | 4 | |a consensus statement | |
| 650 | 4 | |a high-dose intravenous immunoglobulin therapy | |
| 650 | 4 | |a pemphigus foliaceus | |
| 650 | 4 | |a pemphigus vulgaris | |
| 650 | 4 | |a pemphigus-vulgaris | |
| 650 | 4 | |a trial | |
| 700 | 1 | |a Hoffmann, Jochen |e VerfasserIn |0 (DE-588)1074973267 |0 (DE-627)832794430 |0 (DE-576)443176698 |4 aut | |
| 700 | 1 | |a Enk, Alexander |d 1963- |e VerfasserIn |0 (DE-588)1032757140 |0 (DE-627)739272535 |0 (DE-576)166173517 |4 aut | |
| 700 | 1 | |a Hadaschik, Eva |e VerfasserIn |0 (DE-588)1054876916 |0 (DE-627)792376684 |0 (DE-576)410969842 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta dermato-venereologica |d Uppsala : Acta Dermato-Venereologica, 1921 |g 93(2013), 3, Seite 346-349 |h Online-Ressource |w (DE-627)302725431 |w (DE-600)1492617-9 |w (DE-576)081952848 |x 1651-2057 |7 nnas |a Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease high efficacy and no serious adverse events |
| 773 | 1 | 8 | |g volume:93 |g year:2013 |g number:3 |g pages:346-349 |g extent:4 |a Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease high efficacy and no serious adverse events |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2340/00015555-1471 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.ingentaconnect.com/content/mjl/adv/2013/00000093/00000003/art00018 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180629 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1054876916 |a Hadaschik, Eva |m 1054876916:Hadaschik, Eva |d 910000 |d 911300 |e 910000PH1054876916 |e 911300PH1054876916 |k 0/910000/ |k 1/910000/911300/ |p 4 |y j | ||
| 998 | |g 1032757140 |a Enk, Alexander |m 1032757140:Enk, Alexander |d 910000 |d 911300 |e 910000PE1032757140 |e 911300PE1032757140 |k 0/910000/ |k 1/910000/911300/ |p 3 | ||
| 998 | |g 1074973267 |a Hoffmann, Jochen |m 1074973267:Hoffmann, Jochen |d 910000 |d 911300 |e 910000PH1074973267 |e 911300PH1074973267 |k 0/910000/ |k 1/910000/911300/ |p 2 | ||
| 998 | |g 103109377X |a Seidling, Vera |m 103109377X:Seidling, Vera |d 910000 |d 911300 |e 910000PS103109377X |e 911300PS103109377X |k 0/910000/ |k 1/910000/911300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1577032799 |e 3014756288 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Epub ahead of print Oct 16, 2012","Gesehen am 29.06.2018"],"recId":"1577032799","name":{"displayForm":["Vera Seidling, Jochen H.O. Hoffmann, Alexander H. Enk and Eva N. Hadaschik"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["302725431"],"zdb":["1492617-9"],"issn":["1651-2057"]},"language":["eng"],"origin":[{"publisher":"Acta Dermato-Venereologica ; Medical Journals Sweden AB ; Taylor & Francis","dateIssuedDisp":"[1921?]-","publisherPlace":"Uppsala ; Uppsala ; London [u.a.]"}],"titleAlt":[{"title":"ActaDV"}],"title":[{"title_sort":"Acta dermato-venereologica","title":"Acta dermato-venereologica","subtitle":"a journal for clinical and experimental research in the field of dermatology and venereology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"93","pages":"346-349","text":"93(2013), 3, Seite 346-349","year":"2013","extent":"4","issue":"3"},"disp":"Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease high efficacy and no serious adverse eventsActa dermato-venereologica","recId":"302725431","pubHistory":["Volume 2, issue 2 (1921) [?]-"],"note":["Fortsetzung der Druck-Ausgabe","Volltext auch als Teil einer Datenbank verfügbar","Gesehen am 16.10.24"]}],"person":[{"role":"aut","given":"Vera","display":"Seidling, Vera","family":"Seidling"},{"role":"aut","display":"Hoffmann, Jochen","family":"Hoffmann","given":"Jochen"},{"family":"Enk","display":"Enk, Alexander","given":"Alexander","role":"aut"},{"role":"aut","given":"Eva","family":"Hadaschik","display":"Hadaschik, Eva"}],"physDesc":[{"extent":"4 S."}],"title":[{"subtitle":"high efficacy and no serious adverse events","title":"Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease","title_sort":"Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease"}],"id":{"eki":["1577032799"],"doi":["10.2340/00015555-1471"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}]} | ||
| SRT | |a SEIDLINGVEANALYSISOF2013 | ||